Jump to ContentJump to Main Navigation
Show Summary Details
More options …

Clinical Chemistry and Laboratory Medicine (CCLM)

Published in Association with the European Federation of Clinical Chemistry and Laboratory Medicine (EFLM)

Editor-in-Chief: Plebani, Mario

Ed. by Gillery, Philippe / Lackner, Karl J. / Lippi, Giuseppe / Melichar, Bohuslav / Payne, Deborah A. / Schlattmann, Peter / Tate, Jillian R.

12 Issues per year


IMPACT FACTOR 2017: 3.556

CiteScore 2017: 2.34

SCImago Journal Rank (SJR) 2017: 1.114
Source Normalized Impact per Paper (SNIP) 2017: 1.188

Online
ISSN
1437-4331
See all formats and pricing
More options …
Volume 56, Issue 1

Issues

Processing-independent proANP measurement for low concentrations in plasma: reference intervals and effect of body mass index and plasma glucose

Peter D. Mark / Ingrid Hunter / Dijana Terzic / Jens P. Goetze
Published Online: 2017-07-08 | DOI: https://doi.org/10.1515/cclm-2017-0309

Abstract

Background:

Decreased concentrations of pro-atrial-derived natriuretic peptides (proABP) in plasma have been associated with obesity and suggested as a predictor of type 2 diabetes. However, assays for measuring proANP are generally aimed to quantitate higher concentrations of proANP associated with cardiac disease. Therefore, we aimed to measure plasma proANP concentrations in a non-obese Scandinavian reference material and evaluate potential associations of plasma proANP with body mass index (BMI) and plasma glucose, respectively.

Methods:

We report an optimized processing-independent assay (PIA) for proANP in the lower concentration range. The assay was optimized by raising the amount of radioactive tracer and modifying the mixing ratio of resuspended plasma and buffer. Blood samples from a Scandinavian plasma cohort of 693 healthy subjects were then analyzed and age and gender-specific reference intervals were determined.

Results:

Simple linear regression analyses of proANP and both BMI and plasma glucose in fasting subjects displayed insignificant associations. Multiple regression analyses supported these findings. However, a higher median plasma concentration of proANP was noted among women <50 years compared to men, whereas no gender-specific differences were seen in other age groups.

Conclusions:

Our results show that in a healthy non-obese population, BMI and plasma glucose in fasting subjects do not affect plasma proANP concentrations. Our method should be considered for future studies on low proANP concentration studies, e.g. in obesity and diabetes.

Keywords: atrial natriuretic peptide; body mass index; natriuretic peptides; pro-atrial natriuretic peptide; processing-independent assay; reference intervals

References

  • 1.

    Wang TJ, Larson MG, Levy D, Benjamin EJ, Leip EP, Wilson PW, et al. Impact of obesity on plasma natriuretic peptide levels. Circulation 2004;109:594–600.CrossrefPubMedGoogle Scholar

  • 2.

    Zois NE, Bartels ED, Hunter I, Kousholt BS, Olsen LH, Goetze JP. Natriuretic peptides in cardiometabolic regulation and disease. Nat Rev Cardiol 2014;11:403–12.PubMedWeb of ScienceCrossrefGoogle Scholar

  • 3.

    Magnusson M, Jujic A, Hedblad B, Engström G, Persson M, Struck J, et al. Low plasma level of atrial natriuretic peptide predicts development of diabetes: the prospective Malmö diet and cancer study. J Clin Endocrinol Metab 2012;97:638–45.CrossrefGoogle Scholar

  • 4.

    Gaggin HK, Januzzi JL Jr. Biomarkers and diagnostics in heart failure. Biochim Biophys Acta 2013;1832:2442–50.CrossrefPubMedGoogle Scholar

  • 5.

    Goetze JP, Hansen LH, Terzic D, Zois NE, Albrethsen J, Timm A, et al. Atrial natriuretic peptides in plasma. Clin Chim Acta 2015;443:25–8.Web of ScienceCrossrefPubMedGoogle Scholar

  • 6.

    Owan TE, Hodge DO, Herges RM, Jacobsen SJ, Roger VL, Redfield MM. Trends in prevalence and outcome of heart failure with preserved ejection fraction. N Engl J Med 2006;355:251–9.CrossrefPubMedGoogle Scholar

  • 7.

    Hunter I, Rehfeld JF, Goetze JP. Measurement of the total proANP product in mammals by processing independent analysis. J Immunol Methods 2011;370:104–10.CrossrefPubMedWeb of ScienceGoogle Scholar

  • 8.

    Rustad P, Simonsson P, Felding P, Pedersen M. Nordic reference interval project bio-bank and database (NOBIDA): a source for future estimation and retrospective evaluation of reference intervals. Scand J Clin Lab Invest 2004;64:431–8.CrossrefPubMedGoogle Scholar

  • 9.

    Felding P, Rustad P, Mårtensson A, Kairisto V, Franzson L, Hyltoft Petersen P, et al. Reference individuals, blood collection, treatment of samples and descriptive data from the questionnaire in the nordic reference interval project 2000. Scand J Clin Lab Invest 2004;64:327–42.CrossrefPubMedGoogle Scholar

  • 10.

    Hunter I, Alehagen U, Dahlström U, Rehfeld JF, Crimmins DL, Goetze JP. N-terminal pro-atrial natriuretic peptide measurement in plasma suggests covalent modification. Clin Chem 2011;57:1327–30.PubMedWeb of ScienceCrossrefGoogle Scholar

  • 11.

    Arora P, Wu C, Hamid T, Arora G, Agha O, Allen K, et al. Acute metabolic influences on the natriuretic peptide system in humans. J Am Coll Cardiol 2016;67:804–12.PubMedCrossrefGoogle Scholar

  • 12.

    Rehfeld JF, Goetze JP. The posttranslational phase of gene expression: new possibilities in molecular diagnosis. Curr Mol Med 2003;3:25–38.PubMedCrossrefGoogle Scholar

  • 13.

    Gøtze JP, Hunter I, Lippert SK, Bardram L, Rehfeld JF. Processing-independent analysis of peptide hormones and prohormones in plasma. Front Biosci (Landmark Ed.) 2012;17:1804–15.CrossrefWeb of SciencePubMedGoogle Scholar

  • 14.

    Armbruster DA, Pry T. Limit of blank, limit of detection and limit of quantitation. Clin Biochem Rev 2008;29(Suppl 1): S49–52.PubMedGoogle Scholar

  • 15.

    Goetze JP, Mogelvang R, Maage L, Scharling H, Schnohr P, Sogaard P, et al. Plasma pro-B-type natriuretic peptide in the general population: screening for left ventricular hypertrophy and systolic dysfunction. Eur Heart J 2006;27:3004–10.PubMedCrossrefGoogle Scholar

  • 16.

    Rifai N, Horvath AR, Wittwer CT. Tietz textbook of clinical chemistry and molecular diagnostics, 6th ed. Elsevier, 2012.Google Scholar

  • 17.

    Solberg HE. The IFCC recommendation on estimation of reference intervals. The RefVal program. Clin Chem Lab Med 2004;42:710–4.PubMedGoogle Scholar

  • 18.

    Clerico A, Del Ry S, Maffei S, Prontera C, Emdin M, Giannessi D. The circulating levels of cardiac natriuretic hormones in healthy adults: effects of age and sex. Clin Chem Lab Med 2002;40: 371–7.PubMedGoogle Scholar

  • 19.

    Hamada M, Shigematsu Y, Takezaki M, Ikeda S, Ogimoto A. Plasma levels of atrial and brain natriuretic peptides in apparently healthy subjects: effects of sex, age, and hemoglobin concentration. Int J Cardiol 2016;228:599–604.PubMedWeb of ScienceGoogle Scholar

  • 20.

    Tzikas S, Keller T, Wild PS, Schulz A, Zwiener I, Zeller T, et al. Midregional pro-atrial natriuretic peptide in the general population/Insights from the Gutenberg health study. Clin Chem Lab Med 2013;51:1125–33.PubMedGoogle Scholar

  • 21.

    Clerico A, Passino C, Emdin M. When gonads talk to the heart sex hormones and cardiac endocrine function. J Am Coll Cardiol 2011;58:627–8.CrossrefPubMedWeb of ScienceGoogle Scholar

About the article

Corresponding author: Jens P. Goetze, MD, DMSc, Professor, Chief Physician, Department of Clinical Biochemistry (KB3014), Rigshospitalet, Blegdamsvej 9, 2100 Copenhagen, Denmark, Phone: +45-3545-2202, Fax: +45-3545-2880


Received: 2017-04-08

Accepted: 2017-05-12

Published Online: 2017-07-08

Published in Print: 2017-11-27


Author contributions: All the authors have accepted responsibility for the entire content of this submitted manuscript and approved submission.

Research funding: An unrestricted research grant from the Novo Nordisk Foundation.

Employment or leadership: None declared.

Honorarium: None declared.

Competing interests: The funding organization(s) played no role in the study design; in the collection, analysis, and interpretation of data; in the writing of the report; or in the decision to submit the report for publication.


Citation Information: Clinical Chemistry and Laboratory Medicine (CCLM), Volume 56, Issue 1, Pages 132–137, ISSN (Online) 1437-4331, ISSN (Print) 1434-6621, DOI: https://doi.org/10.1515/cclm-2017-0309.

Export Citation

©2018 Walter de Gruyter GmbH, Berlin/Boston.Get Permission

Comments (0)

Please log in or register to comment.
Log in